Clinical Trials Directory

Trials / Completed

CompletedNCT02539706

Menstrual Cycle on Injection Pain of Rocuronium

The Impact of the Menstrual Cycle on Injection Pain of Rocuronium

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Aydin Adnan Menderes University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the effects of rocuronium injection pain to menstrual cycle phases.Half of participants will receive follicular phase, while the other half will receive luteal phase.

Detailed description

Menstrual period includes a spectrum of emotional and somatic symptoms observed in luteal phase of menstrual cycle, which are disappeared after menstruation. During menstrual cycle, fluctuation in sexual hormones results in attitude change and alteration in pain perception. Different studies reported some interactions between sex hormones and central nervous system, which might be linked to activity of serotonin and beta-endorphin in the brain. Pain perception differs during menstrual cycle. It has been recommended that estrogens might have an influence on somatic sensory process. Some studies reported a significant effect of pain sensitivity with higher levels of progesterone and some other studies reported similar patterns for pain perception. There are reports of more complaint of pain in luteal phase of menstruation, which is suggested as the reason for functional changes in women during menstrual cycle.

Conditions

Interventions

TypeNameDescription
DRUGRocuronium 0,6mg/kgpatients at days 8 to 14 of the menstrual cycle were considered to be at the follicular phase and Rocuronium 0,6mg/kg intravenous was applied
DRUGRocuronium 0,6mg/kgpatients at days 18 to 24 of the menstrual cycle were considered to be at the luteal phase and Rocuronium 0,6mg/kg intravenous rocuronium was applied

Timeline

Start date
2014-01-06
Primary completion
2015-09-06
Completion
2015-10-06
First posted
2015-09-03
Last updated
2017-11-29

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02539706. Inclusion in this directory is not an endorsement.